Healthcare Realty Trust (NYSE:HR) Earns "Buy" Rating from BTIG Research

Key Points

• Healthcare Realty Trust's stock received a "buy" rating from BTIG Research with a target price of $20.00, indicating a potential upside of 7.01% from its current price.
• The company reported earnings of $0.41 per share for the last quarter, slightly exceeding analyst expectations of $0.40.
• Various analysts have differing ratings on the stock, with a consensus of a "Hold" and an average price target of $17.67.

BTIG Research reaffirmed their buy rating on shares of Healthcare Realty Trust (NYSE:HR - Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. BTIG Research currently has a $20.00 target price on the real estate investment trust's stock.

Other equities research analysts have also issued reports about the stock. JPMorgan Chase & Co. lowered their price objective on shares of Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating for the company in a report on Thursday, June 26th. Scotiabank upgraded shares of Healthcare Realty Trust from a "sector perform" rating to a "sector outperform" rating and boosted their price objective for the stock from $18.00 to $20.00 in a report on Friday, September 5th. Wall Street Zen lowered shares of Healthcare Realty Trust from a "hold" rating to a "sell" rating in a report on Saturday, May 31st. Finally, Wells Fargo & Company boosted their price objective on shares of Healthcare Realty Trust from $15.00 to $16.00 and gave the stock an "underweight" rating in a report on Wednesday, August 27th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $17.67.

Healthcare Realty Trust Price Performance

Shares of HR traded up $0.05 during trading hours on Wednesday, hitting $18.36. The company's stock had a trading volume of 3,511,718 shares, compared to its average volume of 3,652,184. The business has a 50 day simple moving average of $16.74 and a two-hundred day simple moving average of $16.00. The company has a market cap of $6.45 billion, a price-to-earnings ratio of -15.96 and a beta of 0.94. Healthcare Realty Trust has a 52-week low of $14.09 and a 52-week high of $18.90.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.41 EPS for the quarter, beating the consensus estimate of $0.40 by $0.01. Healthcare Realty Trust had a negative net margin of 32.95% and a negative return on equity of 7.70%. The company had revenue of $287.07 million during the quarter, compared to analysts' expectations of $290.83 million. During the same quarter in the previous year, the company earned $0.38 earnings per share. Healthcare Realty Trust has set its FY 2025 guidance at 1.570-1.610 EPS. Research analysts predict that Healthcare Realty Trust will post 1.59 earnings per share for the current year.

Healthcare Realty Trust Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th were given a $0.24 dividend. The ex-dividend date of this dividend was Thursday, August 14th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 5.2%. Healthcare Realty Trust's dividend payout ratio is currently -83.48%.

Insider Transactions at Healthcare Realty Trust

In other Healthcare Realty Trust news, Director Thomas N. Bohjalian bought 10,000 shares of Healthcare Realty Trust stock in a transaction dated Wednesday, August 13th. The shares were purchased at an average cost of $16.46 per share, with a total value of $164,600.00. Following the transaction, the director directly owned 75,520 shares of the company's stock, valued at $1,243,059.20. This represents a 15.26% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Julie F. Wilson sold 15,000 shares of the stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $18.00, for a total transaction of $270,000.00. Following the sale, the executive vice president directly owned 113,419 shares in the company, valued at $2,041,542. This trade represents a 11.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.37% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Healthcare Realty Trust

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Crossmark Global Holdings Inc. bought a new position in Healthcare Realty Trust in the first quarter worth approximately $228,000. Golden State Wealth Management LLC bought a new position in Healthcare Realty Trust in the first quarter worth approximately $26,000. Oppenheimer Asset Management Inc. raised its position in Healthcare Realty Trust by 31.4% in the first quarter. Oppenheimer Asset Management Inc. now owns 60,301 shares of the real estate investment trust's stock worth $1,019,000 after acquiring an additional 14,400 shares during the period. Sequoia Financial Advisors LLC raised its position in Healthcare Realty Trust by 8.6% in the first quarter. Sequoia Financial Advisors LLC now owns 14,803 shares of the real estate investment trust's stock worth $250,000 after acquiring an additional 1,171 shares during the period. Finally, SG Americas Securities LLC bought a new position in Healthcare Realty Trust in the first quarter worth approximately $618,000.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.